SLNO Prakiraan wutah bathi kanggo taun ngarep soleno.life

Lambang korporat lan logo Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics (SLNO) aims for leadership in the Prader-Willi syndrome therapy niche, supported by strong research positions. However, long-term success depends on FDA approval and the commercialization of the DCCR drug. A potential exit from the development stage is only possible through acquisition by a tech giant. The consensus estimate for net profit growth rates reflects a search for market equilibrium, with the value holding at 73.20.

Soleno (SLNO): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 30.05.2026

SLNO (Soleno Therapeutics Inc): rincian analitis lan laporan miturut indikator

Analisis wiwitan perusahaan:SLNO, soleno.life
Produk dadi Soleno Therapeutics, Inc.

This indicator reflects the consensus forecast for profit growth rates in the coming period by measuring the difference between current and expected EPS. By analyzing the forward net income trend with a value of 73.20, an investor assesses market expectations for the monetization of DCCR by Soleno Therapeutics (SLNO), where monopoly pricing power amid inelastic demand for the Prader-Willi syndrome treatment will serve as the primary growth driver.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Madrigal Pharmaceuticals|Prakiraan wutah bathi kanggo taun ngarep CORT|Prakiraan wutah bathi resik saben saham kanggo taun ngarep RYTM (Rhythm Pharma)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep akerotx.com AKRO|Metsera Therapeutics (MTSR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|MLTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CRNX: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi kanggo taun ngarep|FOLD - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep 89bio Pharma|Agios Corp (AGIO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep structuretx.com (GPCR)|Prakiraan wutah bathi saben saham kanggo taun ngarep mimedx.com MDXG|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MBX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Altimmune Corp - Proyeksi tambahing bathi saben saham ing taun ngarep|Aardvark Therapeutics Inc (AARD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep